medline.ch Gastroenterologie Leber Neoplasie

	Complementary Prognostic Value of ALBI Grade and Child-Pugh Classification in HCC Treated With SBRT. Anticancer Res Nakamura D, Motoyoshi Y, Nagaoka S, Komori A, Toya R. PMID: 42373247 [PubMed - indexed for MEDLINE]
	Balloon-occluded Alternative Infusion of Fragmented Gelatin Particles of TACE for Hepatocellular Carcinoma Refractory to Atezolizumab-Bevacizumab. Anticancer Res Hasegawa N, Hoshiai S, Yamada T, Takahashi N, Mori K, Mori K, Fukuda K, Takizawa D, Amano T, Maruo K, Tsuchiya K, Irie T. PMID: 42373279 [PubMed - indexed for MEDLINE]
	Pretreatment Tumor-infiltrating CD8(+) T Cell Numbers Are Associated With the Response to Tremelimumab Plus Durvalumab in Hepatocellular Carcinoma. Anticancer Res Kuwano A, Yada M, Tanaka K, Hamamoto T, Kurosaka K, Suzuki H, Ohishi Y, Motomura K. PMID: 42373240 [PubMed - indexed for MEDLINE]
	Effects of mindfulness-based stress reduction on perioperative outcomes in patients with advanced hepatocellular carcinoma undergoing transarterial chemoembolization. PLoS One Zhao Y, Li J, Li X, Zhang M, Qin J. PMID: 42371844 [PubMed - indexed for MEDLINE]
	Decoding the functional landscape of long non-coding RNAs in hepatocellular carcinoma: molecular mechanisms, clinical implications, and therapeutic prospects. J Egypt Natl Canc Inst Naveed H, Abidien ZU, Maqsood K, Amin I, Shahid M, Afzal S. PMID: 42371299 [PubMed - indexed for MEDLINE]
	Immune - cell death index in hepatocellular carcinoma: a multi-omics and machine learning study for prognosis and immunotherapy prediction. Front Immunol Zhang Y, Zhao H, Zhai Y, Wang C, Wang Z, Liang R. PMID: 42367826 [PubMed - indexed for MEDLINE]
	Metabolic dysfunction-associated fatty liver disease in chronic hepatitis B: dual effects on hepatocarcinogenesis and evolving strategies for risk prediction. Front Immunol Tao H, Duan Y, Yu G, Yan W, Yin J. PMID: 42367770 [PubMed - indexed for MEDLINE]
	Independent Prognosis Prediction of Hepatocellular Carcinoma Using MicroRNA-Based Single and Combined Biomarkers. Can J Gastroenterol Hepatol Jeng LB, Chan WL, Teng CF. PMID: 42365459 [PubMed - indexed for MEDLINE]
	Risk Group Stratification for True Early Recurrence After Ablation for Hepatomas. Can J Gastroenterol Hepatol Yen YH, Kee KM, Hung CH, Chen CH, Hu TH, Wang JH, Lu SN. PMID: 42365457 [PubMed - indexed for MEDLINE]
	Diagnostic Performance of Serum AKR1B10 in Early-Stage and AFP-Negative Hepatocellular Carcinoma: A Multicentre Study. Liver Int Cao Z, Xie M, Ye X, Wu B, Wang H, Chen G, Cao D, Wang B, Zeng X, Sun Z. PMID: 42363436 [PubMed - indexed for MEDLINE]
	Feasibility Study of Combined Systemic Therapy and Carbon-Ion Radiotherapy for Hepatocellular Carcinoma Patients. Cancer Med Kobayashi D, Shibuya K, Miyasaka Y, Araki K, Yamazaki Y, Shirabe K, Ohno T. PMID: 42363399 [PubMed - indexed for MEDLINE]
	Comprehensive analysis of the RBP regulome reveals functional modules and drug candidates in liver cancer. Sci Rep Garbulowski M, Mosca R, Gallardo-Dodd CJ, Kutter C, Sonnhammer ELL. PMID: 42362666 [PubMed - indexed for MEDLINE]
	Chromatin chronicles: Unlocking the therapeutic potential of histone modifiers in hepatocellular carcinoma. Med Oncol Sulaiman M, Chen Z, Nie Y, Hani UE, Raza F, Mulumba J, Zhang Z, Yang M, Yuan S, Sun C. PMID: 42360649 [PubMed - indexed for MEDLINE]
	Prediction of Ki-67 expression in hepatocellular carcinoma: a dual-center study based on T2-weighted imaging habitat analysis. Radiol Oncol Zheng X, Huang L, Huang M, Yu B, Qin S, Huang D. PMID: 42359754 [PubMed - indexed for MEDLINE]
	Colorectal cancer liver metastasis: immunosuppressive microenvironment, signaling pathways, and emerging therapeutic strategies. Front Immunol Yang H, Wu S, Chen L. PMID: 42358994 [PubMed - indexed for MEDLINE]
	Application of immune checkpoint inhibitors in hepatocellular carcinoma: a landscape analysis of clinical trial databases. Front Immunol Cao J, Chen Y, Zhang L, Lou J, Li S, Wen H, Huang R, Ma L. PMID: 42358968 [PubMed - indexed for MEDLINE]
	Preclinical Models of Colorectal Cancer Liver Metastasis: Therapeutic Evaluation and Translational Implications. Oncol Res Han YR, Lee SB. PMID: 42358838 [PubMed - indexed for MEDLINE]
	Immunometabolic Reprogramming in Hepatocellular Carcinoma Mechanisms, Biomarkers, and Therapeutic Implications. Oncol Res Yu G, Ge W, Yao H, Bai X, Wu J, Wang Y, Bai J, Cui Y, Han J. PMID: 42358827 [PubMed - indexed for MEDLINE]
	Diet-Microbiota-Immune Interactions in Hepatocellular Carcinoma: An Immunometabolic and Spatial Perspective. Nutrients Salem AE, Nassar N, Emam SM, Negm SH, Talib WH, Raposa B. PMID: 42356299 [PubMed - indexed for MEDLINE]
	Deubiquitinating Enzymes as Therapeutic Candidates in Hepatocellular Carcinoma and Other Liver Disease. Int J Mol Sci Jeong YH, Lee HH, Kim YJ, Lee HR, Lim KH. PMID: 42353339 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 76708

Seite 1 von 3836

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung